国药科技股份(08156)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08156 国药科技股份

未开盘 09-30 09:00:00

0.217

+0.000

0.00%

最高0.217	最低0.217	成交量0.00
今开0.217	昨收0.217	日振幅0.00%
总市值1.38亿	流通市值1.38亿	总股本6.34亿
成交额0.00	换手率0.00%	流通股本6.34亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08156","market":"HK","secType":"STK","nameCN":"国药科技股份","latestPrice":0.217,"timestamp":1790730000407,"preClose":0.217,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":634000000,"shares":634000000,"eps":-0.0197,"marketStatus":"未开盘","change":0,"latestTime":"09-30 09:00:00","open":0.217,"high":0.217,"low":0.217,"amount":0,"amplitude":0,"askPrice":0.22,"askSize":50000,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.014,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1037030400000,"exchange":"SEHK","adjPreClose":0.217,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0,"lotSize":10000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08156","defaultTab":"news","newsList":[{"id":"2671248942","title":"国药科技：2026财年净亏损910万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248942","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671248942?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:26","pubTimestamp":1790691974,"startTime":"0","endTime":"0","summary":"南财智讯9月29日电，国药科技（08156.HK）公告，截至2026年6月30日止年度，本公司拥有人应占亏损约910万港元；收入约4560万港元，较2025财年同期的6130万港元减少约26%；毛利约640万港元，较2025财年同期的1420万港元减少约55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609293886779754.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609293886779754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08156","BK1172","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172733849","title":"国药科技2026财年营收下滑26%  深化AI驱动医药供应链转型","url":"https://stock-news.laohu8.com/highlight/detail?id=1172733849","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172733849?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:25","pubTimestamp":1790691908,"startTime":"0","endTime":"0","summary":"国药科技控股有限公司于截至2026年6月30日止财政年度内，在“科技赋能大健康”核心战略指引下，继续重点发展“大健康产业”与“医药供应链服务”两大主营业务，着力结合人工智能及大数据等技术，为供应链以及智能健康服务提供支持。整体来看，国药科技在2026财年营收与盈利能力均受到挑战，亏损加剧，资金与杠杆水平承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"国药科技2026财年营收下滑26%  深化AI驱动医药供应链转型","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113647163","title":"国药科技股份（08156）2026财年收入下滑26%，亏损同比扩大769%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113647163","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113647163?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:15","pubTimestamp":1790691336,"startTime":"0","endTime":"0","summary":"国药科技股份于截至二零二六年六月三十日止年度，录得收入约4,560.00万港元，较上年度的约6,130.00万港元下降约26%。受核心业务收入减少及成本上升等多重因素影响，公司年内亏损由上年的约137.00万港元扩大至约1,190.30万港元，同比增幅约769%，毛利则由上年的约1,420.00万港元降至约640.00万港元。销售及分销费用亦从约164.80万港元上升至约468.50万港元，增幅超过一倍。董事会对 ESG 投入最终责任，确保集团在环境与社会责任方面不断优化管理体系。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"国药科技股份（08156）2026财年收入下滑26%，亏损同比扩大769%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669491356","title":"国药科技股份：2026财年净亏损910万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669491356","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669491356?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"南财智讯9月24日电，国药科技股份（08156.HK）公告，截至2026年6月30日止财年，本公司拥有人应占亏损约910万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609243883949785.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609243883949785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08156","BK1197","BK1172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669459496","title":"国药科技股份(08156.HK)发布年度业绩 股东应占亏损914.2万港元 同比大幅增加954.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669459496","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669459496?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:13","pubTimestamp":1790259214,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08156","BK1197","BK1172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668392153","title":"国药科技股份(08156.HK)发盈警 预计年度股东应占亏损900万至1100万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668392153","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668392153?lang=zh_cn&edition=full","pubTime":"2026-09-18 22:11","pubTimestamp":1789740672,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08156","BK1197","BK1172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163636537","title":"国药科技股份预警：全年亏损预计扩大，供应链收入下滑及推广费用攀升成主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1163636537","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163636537?lang=zh_cn&edition=full","pubTime":"2026-09-18 22:04","pubTimestamp":1789740249,"startTime":"0","endTime":"0","summary":"国药科技股份（08156.HK）发布盈警公告，预期全年亏损幅度将较上年同期显著扩大。业绩转差的核心原因，在于供应链业务收入出现萎缩，叠加市场推广等相关成本持续走高，多重因素共同拖累了整体盈利表现。公司方面指出，除上述两项主要影响因素外，还有其他综合因素对财务状况构成压力，但具体明细尚未完全披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1172","08156","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186360667","title":"国药科技股份（08156）公示公眾持股量跌破25%下限 将于三个月内完成恢复","url":"https://stock-news.laohu8.com/highlight/detail?id=1186360667","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186360667?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:00","pubTimestamp":1789552841,"startTime":"0","endTime":"0","summary":"2026年9月16日，国药科技股份有限公司公告披露，截至公告日，公司公眾持股量约为24.95%，低于香港联交所GEM上市规则第17.37B条规定的25.0%最低公眾持股要求。公司已发行普通股总数为633,693,055股。公司表示，正研究恢复公眾持股量的方案，包括促使有关股东出售所持股份及／或向公眾发行新股份。公司预计将在公告日起三个月内完成恢复。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667604254","title":"国药科技股份(08156)：公众持股量约为24.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667604254","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667604254?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:00","pubTimestamp":1789552807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药科技股份(08156)发布公告，由于本公司就公众持股量要求的无心之失，截至本公告日期，本公司的公众持股量约为24.95%，低于香港联合交易所有限公司GEM证券上市规则第17.37B(1)条所规定的25.0%最低公众持股量要求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496900.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08156","BK1197","BK1172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109577269","title":"国药科技股份（08156）定于9月24日召开董事会审议2025/26财年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1109577269","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109577269?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:31","pubTimestamp":1789126261,"startTime":"0","endTime":"0","summary":"国药科技股份有限公司（08156）11日发布公告称，公司董事会将于2026年9月24日（星期四）召开会议。届时，董事会将审议及批准公司及其附属公司截至2026年6月30日止年度的全年业绩及其刊发事宜。\n除年度业绩外，董事会还将讨论延迟支付公司可换股优先股年度优先分派事宜，并考虑是否向普通股股东派发末期股息（如有）。\n公告显示，截至公告日期，公司董事会由执行董事赵善能先生及郭淑仪女士，以及独立非执行董事刘斐先生、向碧伦先生、刁志强先生及余秉明先生组成。\n根据香港联合交易所有限公司GEM证券上市规则要求，相关公告已于香港联交所网站及公司网站刊载，自刊发日期起至少保留七天。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120896797","title":"国药科技股份更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1120896797","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120896797?lang=zh_cn&edition=full","pubTime":"2026-09-01 21:01","pubTimestamp":1788267690,"startTime":"0","endTime":"0","summary":"2026年9月1日，国药科技股份有限公司公布截至2026年8月31日止当月的证券变动月报表。报告显示，公司本月底法定/注册股本总额为160,000,000港元（普通股）加上40,000,000港元，合计200,000,000港元，与此前保持一致。在员工持股激励方面，2021年购股权计划下的购股权数量本月无新授出或行使。截至8月31日，该计划中结存购股权数量为4,960,000份，也未导致新的股份发行或库藏股转让。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127391209","title":"国药科技股份7月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1127391209","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127391209?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:49","pubTimestamp":1786009759,"startTime":"0","endTime":"0","summary":"国药科技股份有限公司于2026年8月6日发布截至2026年7月31日的月报表。公告显示，公司本月底法定及注册股本合计约为HKD 200,000,000，其中包括12,800,000,000股普通股和3,200,000,000股优先股，与上月底相比无变化。本月末普通股已发行数量为633,693,055股，库存股份数为0，两项数据均与上月底持平，显示公司未进行任何新的股份发行或回购注销操作。公告由执行董事郭淑仪签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191300816","title":"国药科技股份6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1191300816","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191300816?lang=zh_cn&edition=full","pubTime":"2026-07-05 18:37","pubTimestamp":1783247869,"startTime":"0","endTime":"0","summary":"国药科技股份于2026年7月5日披露的截至2026年6月30日止6月股份变动月报表显示，公司在6月期间没有新增股份发行或购回及注销行为，整体股本继续维持稳定。根据公告，国药科技股份于报告期末的法定股本总额为港币200,000,000元，仍分为12,800,000,000股普通股及3,200,000,000股无投票权可换股优先股。公司已发行普通股维持在633,693,055股，已发行优先股维持在1,480,151,050股，均与上月底持平，库存股份数为0，期内无变化。上述公告由公司执行董事郭淑仪签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125075983","title":"国药科技股份2026年5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125075983","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125075983?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:55","pubTimestamp":1780404946,"startTime":"0","endTime":"0","summary":"国药科技股份有限公司于2026年6月1日发布截至2026年5月31日止的股份变动月报表。报告期内，普通股及可换股优先股的已发行股份数目均未发生变化，分别维持在633,693,055股和1,480,151,050股，公司当月没有新增发行、购回或注销股份活动。根据公告，公司符合最低公众持股量要求。另有可换股优先股总额港币148,015,105元，按1:1的转换比例转换为普通股。本次公告由执行董事郭淑仪于2026年6月1日签署，公司确认已遵守香港联交所《上市规则》及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117612374","title":"国药科技股份披露2026年4月股份变动月报，股本维持2.00亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117612374","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117612374?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:01","pubTimestamp":1777986092,"startTime":"0","endTime":"0","summary":"国药科技股份于2026年5月5日披露了截至2026年4月30日止当月的股份变动月报。公司注册股本维持在2.00亿港元，其中普通股法定数额为1.60亿港元，优先股法定数额为4000万港元，均与上月保持一致。公司当月未发生股份发行、购回或注销，股本结构保持稳定。公司确认截至4月末公共持股量符合香港联合交易所有限公司相关上市规则及适用法律要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516153976","title":"国药科技股份盘中异动 临近午盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516153976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516153976?lang=zh_cn&edition=full","pubTime":"2025-03-04 11:41","pubTimestamp":1741059717,"startTime":"0","endTime":"0","summary":"2025年03月04日临近午盘11时41分，国药科技股份股票出现异动，股价快速拉升5.31%。截至发稿，该股报0.119港元/股，成交量2万股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。国药科技股份股票所在的供应链管理行业中，整体涨幅为0.12%。其相关个股中，道和环球、京东物流、滨海泰达物流涨幅较大，振幅较大的相关个股有EDA集团控股、中国海洋发展、百德国际，振幅分别为5.54%、3.70%、3.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304114158abe714d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304114158abe714d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08156","BK1172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514732235","title":"国药科技股份(08156)发布中期业绩，股东应占亏损551.3万港元 同比增加91.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514732235","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514732235?lang=zh_cn&edition=full","pubTime":"2025-02-28 21:34","pubTimestamp":1740749649,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药科技股份(08156)发布截至2024年12月31日止6个月的中期业绩，该集团取得收入1889.8万港元，同比增加0.29%;公司股东应占亏损551.3万港元，同比增加91.69%;每股基本亏损2.17港仙。本集团正持续以供应链业务及大健康产品为主导发展方向，凭藉于供应链服务多年经验及与各大平台运营方的合作关系，本集团于供应链服务及大健康产业上存在广阔的进展空间，本集团正与各产品品牌方商讨扩大产品供应清单，为提高本集团营销金额及扩大营销渠道作好准备，共同开发新市场的可能性，为本集团拓展新的发展机遇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1172","08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514208402","title":"国药科技股份盘中异动 急速下跌5.98%报0.110港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514208402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514208402?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:41","pubTimestamp":1740447689,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘09时41分，国药科技股份股票出现波动，股价大幅下跌5.98%。截至发稿，该股报0.110港元/股，成交量10000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1100港元。国药科技股份股票所在的供应链管理行业中，整体跌幅为0.69%。其相关个股中，滨海泰达物流、国药科技股份、仍志集团控股涨幅较大，振幅较大的相关个股有京东物流、中远海运国际、滨海泰达物流，振幅分别为3.56%、2.03%、0.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225094129a252a622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225094129a252a622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1172","08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513760309","title":"国药科技股份盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513760309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513760309?lang=zh_cn&edition=full","pubTime":"2025-02-24 09:32","pubTimestamp":1740360720,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时32分，国药科技股份股票出现波动，股价快速上涨5.41%。截至发稿，该股报0.117港元/股，成交量10000股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。国药科技股份股票所在的供应链管理行业中，整体涨幅为0.17%。其相关个股中，国药科技股份、滨海泰达物流、大丰港涨幅较大，振幅较大的相关个股有京东物流、中远海运国际、滨海泰达物流，振幅分别为2.44%、1.10%、0.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093200962dce17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093200962dce17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1172","08156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512912156","title":"国药科技股份盘中异动 下午盘急速下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512912156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512912156?lang=zh_cn&edition=full","pubTime":"2025-02-19 14:53","pubTimestamp":1739948019,"startTime":"0","endTime":"0","summary":"2025年02月19日下午盘14时53分，国药科技股份股票出现波动，股价大幅下跌5.31%。截至发稿，该股报0.107港元/股，成交量13.68万股，换手率0.02%，振幅7.08%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。国药科技股份股票所在的供应链管理行业中，整体跌幅为0.47%。其相关个股中，EDA集团控股、中国华君、滨海泰达物流涨幅较大，振幅较大的相关个股有中国华君、EDA集团控股、道和环球，振幅分别为42.31%、25.71%、13.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219145340a24b8115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219145340a24b8115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08156","BK1172"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cvg.com.hk","stockEarnings":[{"period":"1week","weight":0.096},{"period":"1month","weight":0.391},{"period":"3month","weight":0.069},{"period":"6month","weight":-0.2517},{"period":"1year","weight":-0.0046},{"period":"ytd","weight":-0.2767}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0676},{"period":"6month","weight":-0.02},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药科技股份有限公司是一家主要从事大健康产业及药品供应链业务的投资控股公司。该公司通过三个部门运营业务。供应链服务分部从事提供供应链管理、数据分析及相关服务及贸易相关货品，以及贸易医疗及相关产品。互联网+解决方案服务分部从事提供互联网+解决方案服务，提供互联网相关解决方案服务。制造及分销个人防护装备分部从事制造及销售个人防护装备及消耗品以及其他相关货品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.123218},{"month":2,"riseRate":0.333333,"avgChangeRate":0.013986},{"month":3,"riseRate":0.25,"avgChangeRate":-0.077347},{"month":4,"riseRate":0.25,"avgChangeRate":-0.056954},{"month":5,"riseRate":0.458333,"avgChangeRate":0.091957},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.060911},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.007588},{"month":8,"riseRate":0.291667,"avgChangeRate":-0.014268},{"month":9,"riseRate":0.375,"avgChangeRate":0.070048},{"month":10,"riseRate":0.545455,"avgChangeRate":0.122854},{"month":11,"riseRate":0.409091,"avgChangeRate":0.077103},{"month":12,"riseRate":0.458333,"avgChangeRate":-0.001405}],"exchange":"SEHK","name":"国药科技股份","nameEN":"SINOPHARM TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药科技股份(08156)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药科技股份(08156)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药科技股份,08156,国药科技股份股票,国药科技股份股票老虎,国药科技股份股票老虎国际,国药科技股份行情,国药科技股份股票行情,国药科技股份股价,国药科技股份股市,国药科技股份股票价格,国药科技股份股票交易,国药科技股份股票购买,国药科技股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药科技股份(08156)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药科技股份(08156)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}